Ozempic prior authorization: what to submit
An Ozempic prior authorization is a diabetes request. The plan is checking the diagnosis; weight is not on the label, and a request that reads as weight loss is refused as off-label.
What does an Ozempic prior authorization need?
A type 2 diabetes diagnosis with a recent A1c, and for the cardiovascular or kidney indication the heart or kidney diagnosis as well. No history of medullary thyroid carcinoma or MEN 2, and no second GLP-1. A request without diabetes is outside the label.
The use, and what it needs
Type 2 diabetes
Who the label covers: Adults with type 2 diabetes: glycemic control; reducing major cardiovascular events where cardiovascular disease is established; and reducing kidney decline and cardiovascular death in chronic kidney disease.
- The type 2 diabetes diagnosis with a recent A1c. Without it the request is for an off-label use.
- For the cardiovascular or kidney indication, that diagnosis too, dated in the chart.
- If the plan's list prefers another GLP-1, the history of trying it — or the reason it is unsuitable. A documented contraindication or failure is the usual way past a step.
Indications read from FDA prescribing information for OZEMPIC, via DailyMed.
What every request carries
- No personal or family history of medullary thyroid carcinoma or MEN 2. It is the boxed warning, and every published GLP-1 criteria set asks; a blank answer is read as a fail.
- No second GLP-1 alongside it. Every state document on this site that addresses it says so, and a pharmacy claims history is how they check.
- Diet and physical activity as part of treatment. The label pairs every use with them, and criteria ask for it in writing.
- The indication written on the request in the label's words. A form that reads 'weight loss' invites a weight-loss exclusion even when the diagnosis behind it is something else.
How long the plan has
Set by regulation for each plan type, not by the plan. Which one you are on decides the clock.
Employer and marketplace plans
A standard prior authorization has to be decided within 15 days of the request, extendable once by 15; an urgent one within 72 hours. You have at least 180 days from a denial to appeal inside the plan, then four months from the final denial to ask for independent external review, unless the plan is grandfathered. 29 CFR 2560.503-1; 45 CFR 147.136
Medicare Part D, on its own or inside Medicare Advantage
72 hours for a standard coverage determination and 24 for an expedited one; for an exception the clock starts when the prescriber's supporting statement arrives. 60 days from the notice to ask the plan for a redetermination, longer if you show good cause. 42 CFR 423.568; 42 CFR 423.572; 42 CFR 423.582
Medicaid, fee-for-service or managed care
Federal Medicaid law requires an answer to a drug prior authorization within 24 hours, and a 72-hour emergency supply while it is pending. In a managed care plan you have 60 days from a denial to appeal to the plan, which must decide within 30 days, or 72 hours if it is urgent. On a decision the state makes itself, it may allow up to 90 days to ask for a fair hearing. Social Security Act §1927(d)(5); 42 CFR 438.402; 42 CFR 438.408; 42 CFR 431.221
Where your plan's own criteria are
Ozempic prior authorization, answered
- Does Ozempic need prior authorization?
- Often, and what it checks is the diabetes diagnosis. Some plans also require a preferred GLP-1 first; your plan's formulary says which.
- Can I get Ozempic approved for weight loss?
- Not as a covered use: weight loss is not on its label. The semaglutide approved for weight is Wegovy, and a request for Wegovy is judged on the plan's weight-management criteria — or refused under its exclusion.